NABEL; Gary

Patent Applications and Registrations

Patent applications and USPTO patent grants for NABEL; Gary.The latest application filed is for "expression of antigen-binding proteins in the nervous system".

Company Profile

6.21.23

NABEL; Gary - Chestnut Hill MA
Nabel; Gary - Bridgewater NJ
Nabel; Gary - Bethesda MD
Nabel; Gary - Cambridge MA
Nabel; Gary - Washington DC
Nabel; Gary - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Expression Of Antigen-binding Proteins In The Nervous System App 20220213506 - ELMER; Bradford ; et al.	2022-07-07
Anti-CD38 antibodies and methods of use Grant 11,186,649 - Wu , et al. November 30, 2	2021-11-30
Trispecific Anti-cd38, Anti-cd28, And Anti-cd3 Binding Proteins And Methods Of Use For Treating Viral Infection App 20200140552 - WU; Lan ; et al.	2020-05-07
Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing Grant 10,273,291 - Mascola , et al.	2019-04-30
Anti-cd38 Antibodies And Methods Of Use App 20190106504 - WU; Lan ; et al.	2019-04-11
Neutralizing GP41 antibodies and their use Grant 10,047,148 - Connors , et al. August 14, 2	2018-08-14
Neutralizing antibodies to HIV-1 and their use Grant 10,035,845 - Mascola , et al. July 31, 2	2018-07-31
Neutralizing Gp41 Antibodies And Their Use App 20180002406 - Connors; Mark ; et al.	2018-01-04
Neutralizing Antibodies To Hiv-1 And Their Use App 20170369558 - Mascola; John ; et al.	2017-12-28
HIV-1 broadly neutralizing antibodies Grant 9,796,774 - Mascola , et al. October 24, 2	2017-10-24
Neutralizing GP41 antibodies and their use Grant 9,783,595 - Connors , et al. October 10, 2	2017-10-10
Neutralizing antibodies to HIV-1 and their use Grant 9,738,703 - Mascola , et al. August 22, 2	2017-08-22
Neutralizing Gp41 Antibodies And Their Use App 20160333076 - Connors; Mark ; et al.	2016-11-17
Neutralizing GP41 antibodies and their use Grant 9,475,862 - Connors , et al. October 25, 2	2016-10-25
Novel Hiv -1 Broadly Neutralizing Antibodies App 20160289305 - Mascola; John ; et al.	2016-10-06
HIV-1 broadly neutralizing antibodies Grant 9,382,311 - Mascola , et al. July 5, 2	2016-07-05
Neutralizing Antibodies To Hiv-1 And Their Use App 20160009789 - Mascola; John ; et al.	2016-01-14
Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures Grant 9,012,618 - Sullivan , et al. April 21, 2	2015-04-21
Immunogens Based On An Hiv-1 V1v2 Site-of-vulnerability App 20140348865 - Kwong; Peter ; et al.	2014-11-27
Neutralizing Gp41 Antibodies And Their Use App 20140348785 - Connors; Mark ; et al.	2014-11-27
Focused Evolution Of Hiv-1 Neutralizing Antibodies Revealed By Crystal Structures And Deep Sequencing App 20140205607 - Mascola; John R. ; et al.	2014-07-24
Conformationally stabilized HIV envelope immunogens Grant 8,715,686 - Kwong , et al. May 6, 2	2014-05-06
Novel Hiv -1 Broadly Neutralizing Antibodies App 20130251726 - Mascola; John ; et al.	2013-09-26
Conformationally Stabilized Hiv Envelope Immunogens App 20120328641 - Kwong; Peter ; et al.	2012-12-27
Neutralizing Antibodies To Hiv-1 And Their Use App 20120282264 - Mascola; John R. ; et al.	2012-11-08
Conformationally stabilized HIV envelope immunogens Grant 8,268,323 - Kwong , et al. September 18, 2	2012-09-18
Optimized Vaccines To Provide Protection Against Ebola And Other Viruses App 20120156239 - Sullivan; Nancy ; et al.	2012-06-21
Conformationally Stabilized Hiv Envelope Immunogens App 20120034255 - Kwong; Peter ; et al.	2012-02-09
Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector Grant 8,101,739 - Sullivan , et al. January 24, 2	2012-01-24
Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes Grant 8,044,185 - Kwong , et al. October 25, 2	2011-10-25
Conformationally Stabilized Hiv Envelope Immunogens And Triggering Hiv-1 Envelope To Reveal Cryptic V3-loop Epitopes App 20090191235 - Kwong; Peter ; et al.	2009-07-30
Non-viral Gene Delivery Complex App 20090155853 - Nabel; Gary ; et al.	2009-06-18
Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens App 20090110690 - Kwong; Peter D. ; et al.	2009-04-30
Assays for assembly of Ebola virus nucleocapsids Grant 7,449,190 - Nabel , et al. November 11, 2	2008-11-11
Assays for assembly of ebola virus nucleocapsids App 20050180993 - Nabel, Gary ; et al.	2005-08-18
Development of a preventive vaccine for filovirus infection in primates App 20040259825 - Nabel, Gary ; et al.	2004-12-23
Pharmaceutical compositions containing one or more lymphocyte growth factors Grant 4,720,482 - Cantor , et al. January 19, 1	1988-01-19
Lymphocyte growth factor Grant 4,613,459 - Cantor , et al. September 23, 1	1986-09-23
Assay methods and systems utilizing mast cell clones Grant 4,559,310 - Cantor , et al. December 17, 1	1985-12-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.